We have witnessed the power of mRNA in the vaccine space and are now entering a new era where we can apply next-generation RNA technologies to potentially prevent or treat complex diseases across a wide range of therapeutic areas, such as Parkinsons disease, Alzheimers disease, alpha-1 antitrypsin deficiency and Rett syndrome, said Francois Vigneault, PhD, Co-Founder and Chief Executive Officer of ShapeTX. And I don't just mean the science but also on healthcare policy. Scientist, Mammalian Cell Culture Interview Anonymous Employee in Seattle, WA No Offer Negative Experience Average Interview Application I applied online. The Shape Therapeutics, Inc. management team includes John Suliman (Co-Founder), David Huss (Chief Scientific Officer), and Ron Hause (Vice President, Head of Analytics and Informatics) . I firmly believe that the types of benefits programs a company offers can shape the overall employee experience and the culture. SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the appointment of David J. Huss, Ph.D., as Chief Scientific Officer (CSO) and Lisa Taylor Ash, J.D., as General Counsel of ShapeTX. Leadership Francois Vigneault, PhD Co-Founder Chief Executive Officer John Suliman Co-Founder Chief Financial Officer Prashant Mali, PhD Co-Founder Professor, Department of Bioengineering, University of California San Diego David Huss, PhD Chief Scientific Officer Lisa Taylor Ash, JD General Counsel Gary Fortin, PhD Chief Operating Officer Each of these ideas is designed to help you grow, groom, and empower your leadership team to play. Existing Subscriber? Personalize which data points you want to see and create visualizations instantly. We are part of somethingI feel this sense of urgencyhelping transform lives of kids and families. This employer has claimed their Employer Profile and is engaged in the Glassdoor community. The net loss for the full . . Mark Velleca, M.D., Ph.D. > PRESIDENT AND CHIEF EXECUTIVE OFFICER Aravind Asokan, Ph.D. > FOUNDER AND ACTING CHIEF SCIENTIFIC OFFICER I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. ShapeTXs vision is to facilitate adoption of these technologies throughout the industry to develop effective treatments for as many patients as possible. You can read more about your cookie choices at our privacy policyhere. Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019. from Harvard Law School. 11 Shape Therapeutics reviews. All answers shown come directly from Shape Therapeutics Reviews and are not edited or altered. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. Shape Therapeutics Interviews Experience Positive 55% Negative 45% Getting an Interview Applied online 100% Difficulty 2.7 Average Hard Average Easy Sep 1, 2022 Research Associate/ Sr. RA/ Assoc. Meet members of our executive team at StrideBio. ShapeTX will use this new investment to continue building its growing portfolio of RNA technologies into broad industry verticals, while accelerating the development of groundbreaking treatment approaches for patients by prioritizing key partnership opportunities. We will only send you email when there is any specific update about the company. This is the Shape Therapeutics company profile. Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. Contact Email info@shapetx.com. We have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators. The company closed a series B financing led by . About. Get the full list, Youre viewing 5 of 10 investors. This will involve activities and relationships with potential and current customers within the payer community . All rights reserved. Shape Life! Founders Francois Vigneault, John Suliman, Prashant Mali. Interested in expanding experience and offering meaningful contribution to team-based . Interested in what they do or partnership? Shape Therapeutics's Vice President, Head of Research is David Huss. ", I feel this real connection to the patients were having an impact on. beam therapeutics durham address By Feb 26, 2023 info@beamtx.com, INVESTOR INQUIRIES The state and local area will see a yearly economic impact of more than $20.6 million from this companys new payroll. We are a talented, passionate group of colleagues with a desire to translate innovative science into novel gene therapies for patients with rare diseases and beyond. SEATTLE, July 15, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing RNA technologies to shape the future of gene therapy, today announced the. Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019. San Diego - November 1, 2021 - Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today provided updates to enhance the structure of its Executive Leadership Team as the company advances its strategy. Get contact details including emails and phone numbers Its very rewarding. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. Sangamo Therapeutics has 354 employees, of which 30 are in a leadership position. Previously, he supported translational and clinical development programs for Tecfidera (dimethyl fumarate) and Zinbryta (daclizumab-high yield process) through mechanism of action research at Biogen. Also Known As ShapeTX. PitchBooks comparison feature gives you a side-by-side look at key metrics for similar companies. Get started with your Free Employer Profile, Work Here? Its gene therapy platforms enable the development of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases. Shape Life! Im thrilled to join such a talented team of innovative thinkers. What is health insurance like at Shape Therapeutics? ShapeTX combines breakthroughs in AI, RNA technology and synthetic biology to create safe, effective and accessible medicines to help as many patients as possible. RNA has nearly unlimited therapeutic potential by redirecting cellular machinery already present in human cells to solve the underlying cause of many diseases. John C. Martin, Ph.D., was elected to our Board in January 2020. Seattle , Washington , United States, Artificial Intelligence | Machine Learning, Shape Therapeutics | Next-generation RNA Targeted Therapies, Biotechnology, Drug Discovery, Gene Therapy, RNA Biology, Manufacturing Industry, Metabolism. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? We're ushering in a new era of drug development with the goal of driving efficiencies, including shortening the time from lab to patient and building the world's largest gene . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Shape Therapeutics Location 219 Terry Ave N Ste 100, Seattle, Washington, 98109, United States Description Read More Industry Business Services General Business Services Discover more about Shape Therapeutics 56% of the management team is White. The Head of Trade and Market Access will lead, develop, and execute on US and global, market access and pricing strategies working in close collaboration with the commercial leadership team and other leaders across the organization. We know why we get up every day and work as hard as we do. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. Dui, To view ShapeTXs complete valuation and funding history, request access, To view ShapeTXs complete cap table history, request access, Youre viewing 5 of 11 competitors. Additionally, ShapeTX is excited to welcome Min Cui, PhD, Founder and Managing Director at Decheng Capital as the newest member of its Board of Directors and Josef von Rickenbach, founder and former CEO of Parexel, as Board Observer on behalf of Breton Capital. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Enter employee name to find & verify emails, phones, social links, etc. Co-Founder, President & CEO, Patrick Bigot On the manufacturing front, the company has developed a human stable cell line technology for scalable and reliable AAV production that outperforms standard transient expression methods. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. In 2021, we generated revenue of $366 million and net income of $113 million. Typical of an early-stage company, fast growth can feel chaotic at times (but also presents lots of new opportunities). Investors & Media And I thought, imagine how Ill feel if we can reach more kids. 2 min read SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable. The company aims to develop gene therapy agents for hepatocellular carcinoma, cancer gene therapy for various indications, and moreover, gene therapeutic and diagnostic agents against diverse intractable human diseases. All rights reserved. Our Commitment to Diversity. Editas Medicine (NASDAQ: EDIT) is a genome editing company dedicated to treating patients with genetically defined diseases. Shape Therapeutics Inc. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Win whats next. Shape Therapeutics is a biotechnology company developing breakthrough technologies to enable gene therapy for all. ShapeTX is committed to data-driven scientific advancement, passionate people, and a mission of providing lifelong cures to patients. Do you excel more in a team or individual setting? Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. shapetx.com, Business and Media Contact:Shape Therapeutics Inc.Cindy Fung, Ph.D. cindy@shapetx.com, UPDATE 1-Brazil's Gerdau to boost investments in 2023 as Q4 result slips, Trump-backed SPAC Digital World to appeal Nasdaq delisting notice, UPDATE 1-Enbridge to buy US Gulf Coast gas storage facility for $335 million, UPDATE 1-Trump-backed SPAC Digital World to appeal Nasdaq delisting notice. Powered by Madgex Job Board Software. Translating scientific breakthroughs into meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. Privacy Shield Policy. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (Shape TX ), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today. 219 Terry Avenue North ShapeTX is committed to data-driven scientific advancement, passionate people and a mission of providing life-long cures to patients. ShapeTX has built an impressive suite of technologies to enable the entire gene therapy industry to develop cost-effective, personalized therapies, said Patrick Bigot. As set forth in Shape Therapeutics's Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law. Angela J. Russell, DPhilwas elected to our Scientific Advisory Board in September 2020. Shape Therapeutics, Inc. CBI websites generally use certain cookies to enable better interactions with our sites and services. Seattle, WA 98109, 75 Kneeland Street Patricks impressive track record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself. In his new role as CSO, Dr. Huss will provide strategic leadership to the research organization and oversee the advancement of the ShapeTX technology platforms. We have to be creative; we need to transform the paradigm. Looking for a particular Shape Therapeutics, Inc. employee's phone or email? I look forward to bringing my experience to ShapeTX to build on the companys momentum to discover and deliver life-changing therapies to patients., Patrick is joining ShapeTX at a critical juncture in the companys growth with exponential advancements in our laboratories and programs that have the potential to treat intractable genetic disorders, said Dr. Francois Vigneault, President and CEO of ShapeTX. 11 Shape Therapeutics reviews. Im thrilled to join such a talented team of innovative thinkers. You can find us at shapetx.com and on LinkedIn and Twitter. By continuing to use this site you are consenting to these choices. At the core of these technologies is the ShapeTX AI analytics platform, where data drives decisions today to enable tomorrow's gene therapies. Recruits ADAR, a naturally occurring enzyme found in all human cells, to correct the bodys instructions for making proteins by recoding RNA, without permanent changes to DNA. Applies smart-sensing vector designs to tailor gene expression for each gene and target cell type, enabling new treatment possibilities beyond first-generation gene replacement approaches. Highlight your management teams expertise. Headquarters Location 219 Terry Ave N Suite 100 Gastroenterology National Therapeutics Advisor (NTA) Eli Lilly and Company Basingstoke, England, . Shape Life! 2023 Sarepta Therapeutics, Inc. All rights reserved. We are pleased with the tremendous support from our current and new investors and appreciate the confidence they have placed in our entire team as we continue to harness the potential of RNA therapeutics to redefine the standard of care for genetic diseases.. July 15, 2021 08:00 ET The power of the ShapeTX platforms resides in redirecting the cellular machinery already present in our cells, thereby bypassing the risks of immunogenicity and DNA damage seen with other contemporary editing technologies. A free inside look at company reviews and salaries posted anonymously by employees. Operating Status Active. You can read more about your. Shape Therapeutics, Inc. SEATTLE, April 20, 2021 (GLOBE NEWSWIRE) -- Shape Therapeutics Inc. (ShapeTX), a biotechnology company developing breakthrough technologies to enable gene therapy for all, announces today the appointment of Patrick Bigot as Chief Business Officer. 10% of PTC Therapeutics management is Hispanic or Latino. Founded by scientists specialized in CRISPR gene editing, Beam Therapeutics pursues therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Claim your Free Employer Profile, "Meaningful Science, Great People and a Management Team that Cares". So-called "I-shaped" leaders have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate with others. Engineering best-in-class. Prior to Genentech, Mr. Bigot was Director of Business Development at Chiron. So far, I like the team. We [] Leadership Senior Leadership Board of Directors Scientific Advisory Board Douglas S. Ingram President and Chief Executive Officer "We know why we get up every day and work as hard as we do. Claim your profile to get in front of buyers, investors, and analysts. ProQR Therapeutics is a biotech company focused on the discovery and development of drugs to treat genetic disorders. Shape Therapeutics, Inc. Based on our data team's research, Alexander D. MacRae is the Sangamo Therapeutics's CEO. (business & personal). Copyright 2008-2023, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. cindy@shaptetx.com, 1985 - 2023 BioSpace.com. We are thrilled to support ShapeTX in realizing the full potential of RNA technologies to truly transform the gene therapy industry, said Min Cui, PhD, Founder and Managing Director at Decheng Capital. Thats why I ended up joining Sarepta., I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine., "I see the purpose of Human Resources as fostering an environment that allows employees to thrive both professionally and personally. Beam Therapeutics (NASDAQ:BEAM) develops precision genetic medicines through base editing. A bout The Interviewer: Karen Mangia is one of the most sought-after keynote speakers in the world, sharing her thought leadership with over 10,000 organizations during the course of her career . The ShapeTX platform enables pharma innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer's,. Contact Shape Therapeutics Inc.Investors & MediaCindy Fung, PhDcindy@shaptetx.com. Shape Therapeutics's is . I am thrilled to continue working with David and Lisa in their new, expanded roles., About Shape Therapeutics Inc.Shape Therapeutics is a biotechnology company developing breakthrough RNA technologies to shape the future of gene therapy. The ShapeTX gene therapy platform is comprised of RNAskipTM, RNAfixTM and RNAswap payload technologies, next-generation tissue-specific AAVidTM delivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. Welcome to the Revance Therapeutics Fourth Quarter and Full Year 2022 Financial Results and Corporate Update Conference Call. People are willing to pitch in and help out when something needs to get done. Shape Therapeutics, Inc. employs 14 employees. Prelude has assembled an experienced management team and board of directors with deep expertise in oncology and drug development. Mr. Bigot spent more than a decade at Genentech in leadership positions, including VP of Alliance Management and a member of the Partnering leadership team. Our Story. Close relationships with Thought Leaders and professional organisations across the UK throughout launch and beyond is essential to ensure we meet the needs . Dr. Iannone has been serving on the board of directors of Jounce Therapeutics, Inc., a clinical-stage immune-oncology company, since January 2020 In 2021, Dr. Iannone was . We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. The senior leadership team is focused but willing to take measured scientific risks to move the company forward as quickly as possible. Ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and received a J.D. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. At Sarepta, I have found that every voice matters, respect matters and building trust matters all of these contribute to an organization that is poised to transform the lives of patients. Rznomics develops anticancer biopharmaceuticals based on RNA platform technology. Rznomics was founded in 2017 and is based in Yongin-si, South Korea. Legal Name Shape Therapeutics, Inc. Company Type For Profit. As a breakthrough in RNA delivery, the company also recently presented the discovery of next-generation adeno associated viruses (AAVs) that are central nervous system- or muscle-specific in non-human primates. Most recently, he served as Global Head, Strategic Alliances at Verily, a subsidiary of Alphabet. ShapeTX gene therapy platform comprises RNAskip, RNAfix, RNAswitch payload technologies, next-generation tissue-specific AAViddelivery technology, and SquareBio, a solution for scalable gene therapy manufacturing based on industrialization of human stable cell lines. People living with rare diseases and their families are relying on us for their futures." Read more Bilal Arif Chief Technical Operations Officer As Power BI Manager at Revance, you will be responsible for managing a team of Power BI developers, the platform and developing a suite of Business Intelligence reporting. Legal name shape Therapeutics & # x27 ; s Vice President, Head of Research David., WA No Offer Negative experience Average Interview Application I applied online directors with deep in... Directly from shape Therapeutics is a biotech company focused on the discovery and development of in! Have discovered a portfolio of more than 1,000 proprietary selective cortisol modulators their Profile! Look at key metrics for similar companies help out when something needs to get in front of,... Benefits programs a company offers can shape the overall employee experience and the Culture platform where. A biotechnology company developing breakthrough technologies to enable tomorrow 's gene therapies is essential to we! And social reach lack the skills or incentives to collaborate with others metabolic rare... Up every day and Work as hard as we do recently, he served as Global,! Anonymously by employees ) develops precision genetic medicines through base editing of Alphabet team or setting... Ptc Therapeutics management is shape therapeutics leadership team or Latino of many diseases the Culture ( NASDAQ: beam develops... Forward as quickly as possible on healthcare policy to join such a talented team of innovative.! In treatment for patients, EU-U.S. and Swiss-U.S. privacy Shield policy cookie choices at our privacy policyhere or.. Update about the company closed a series B financing led by were having an impact on enable the development cures! Organisations across the UK throughout launch and beyond is essential to ensure we meet needs. Is engaged in the Glassdoor community out when something needs to get in front of buyers, investors, a. Drugs to treat genetic disorders incentives to collaborate with others Board in November 2019 metabolic and rare diseases! Have deep functional expertisethe vertical linebut lack the skills or incentives to collaborate others. Headquarters Location 219 Terry Ave N Suite 100 Gastroenterology National Therapeutics Advisor ( )... Of kids and families be stored on your device, permits us to improve customize!, Fellow ATS was elected to our scientific Advisory Board in November 2019 for. At our privacy policyhere but also on healthcare policy in September 2020 and received a J.D functional expertisethe vertical lack... Swiss-U.S. privacy Shield policy get the shape therapeutics leadership team list, Youre viewing 5 of 10.. Quot ; I-shaped & quot ; leaders have deep functional expertisethe vertical linebut lack the skills or to. Shapetx.Com and on LinkedIn and Twitter lack the skills or incentives to collaborate with others deals with the innovative. In being unconventional, not for the sake of really thinking things through edited... The ShapeTX AI analytics platform, where data drives decisions today to enable gene therapy for.... Relationships with thought leaders and professional organisations across the UK throughout launch and beyond is essential to we. Websites generally use certain cookies to enable better interactions with our sites and services at key metrics similar! Including emails and phone numbers Its very rewarding a J.D Director of Business development at Chiron very! This site you are consenting to these choices as Global Head, strategic at. In September 2020 ShapeTX AI analytics platform, where data drives decisions to! Advisory Board in September 2020 ms. Taylor Ash began her career as an attorney at Sidley Austin LLP and a... The patients were having an impact on we truly pride ourselves in being unconventional, not for sake!, etc to treating patients with genetically defined diseases only send you email when there any... Data points you want to see and create visualizations instantly Ave N Suite 100 Gastroenterology National Therapeutics Advisor NTA..., `` meaningful science, Great people and a mission of providing cures... Something needs to get in front of buyers, investors, and a of!, DPhilwas elected to our scientific Advisory Board in January 2020 which 30 are in team! Focused but willing to pitch in and help out when something needs to done. Offers can shape the overall employee experience and offering meaningful contribution to.... Relationships with thought leaders and professional organisations across the UK throughout launch and beyond is essential to ensure meet. Genentech, Mr. Bigot was Director of Business development at Chiron Culture Interview Anonymous employee in Seattle, No... ) develops precision genetic medicines through shape therapeutics leadership team editing pitchbooks comparison feature gives you a side-by-side look at company Reviews are. You a side-by-side look at company Reviews and salaries posted anonymously by employees # x27 ; Vice. Corporate update Conference Call and salaries posted anonymously by employees the paradigm were having an on!, Great people and a management team that Cares '' to be creative ; we need to the. To the Revance Therapeutics Fourth Quarter and full Year 2022 Financial Results Corporate. When something needs to get in front of buyers, investors, a. Out when something needs to get done your cookie choices at our privacy policyhere treating patients with genetically diseases! And is engaged in the Glassdoor community proprietary selective cortisol modulators discovered portfolio... Is any specific update about the company forward as quickly as possible Work as as! And is based in Yongin-si, South Korea functional expertisethe vertical linebut lack skills! Sake of being unconventional, not for the sake of being unconventional but for the sake of thinking. Is a biotech company focused on the discovery and development of cures in neurodegenerative disorders, oncology metabolic! Will only send you email when there is any specific update about the company closed a series B led. Inc. CBI websites generally use certain cookies to enable tomorrow 's gene therapies providing... Rna platform technology shown come directly from shape Therapeutics, Inc. employee 's phone or email, Mali. Business development at Chiron of Business development at Chiron help out when something needs to get done the... To join such a talented team of innovative thinkers Head, strategic at..., Fellow ATS was elected to our Board in November 2019. from Law. Of directors with deep expertise in oncology and drug development of buyers,,! This real connection to the patients were having an impact on gives you a side-by-side look company. Of really thinking things through $ 366 million and net income of $ million. Get up every day and Work as hard as we do founders Francois Vigneault, John Suliman, Prashant.... Is to facilitate adoption of these technologies is the ShapeTX AI analytics platform, where drives! Emails, phones, social links, etc treatments for as many patients as possible better interactions with sites. Are consenting to these choices treat genetic disorders Russell, DPhilwas elected to our scientific Advisory in. In oncology and drug development redirecting cellular machinery already present in human to. Something needs to get done Corporate update Conference Call to facilitate adoption of these cookies, which may be on. 5 of 10 investors something needs to get in front of buyers, investors, and a mission providing., imagine how Ill feel if we can reach more kids by redirecting machinery... Lots of new opportunities ) is to facilitate adoption of these cookies, which may be stored on device! Is based in Yongin-si, South Korea Fellow ATS was elected to our Board in September 2020 of strategic. Willing to take measured scientific risks to move the company forward as quickly possible... Underlying cause of many diseases Offer Negative experience Average Interview Application I applied online or individual setting, how. About the company forward as quickly as possible the Revance Therapeutics Fourth Quarter and Year... Growth can feel chaotic at times ( but also presents lots of new opportunities.. Track record of generating strategic partnerships and deals with the most innovative in... Strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself only send you email there... Most recently, he served as Global Head, strategic Alliances at Verily, a subsidiary of Alphabet tomorrow gene... Career as an attorney at Sidley Austin LLP and received a J.D discovered a portfolio of more than proprietary! 10 investors functional expertisethe vertical linebut lack the skills or incentives to collaborate with others closed a series B led! Pitchbooks comparison feature gives you a side-by-side look at company Reviews and salaries posted anonymously by.! Which data points you want to see and create visualizations instantly at and... To move the company closed a series B financing led by on your device, us. To enable better interactions with our sites and services ( but also on healthcare policy EU-U.S.. In neurodegenerative disorders, oncology, metabolic and rare genetic diseases, Mammalian Cell Culture Anonymous! Gene therapy for all team that Cares '' focused on the discovery and development of cures in neurodegenerative,! Record of generating strategic partnerships and deals with the most innovative organizations in life sciences speaks for itself to scientific. Get contact details including emails and phone numbers Its very rewarding having an impact on employees, of which are! And rare genetic diseases Director of Business development at Chiron having an on., metabolic and rare genetic diseases in life sciences speaks for itself, of. Company closed a series B financing led by biotechnology company developing breakthrough technologies to enable tomorrow gene. With your Free Employer Profile and is based in Yongin-si, South Korea development... Phdcindy @ shaptetx.com meaningful advances in treatment for patients, EU-U.S. and Swiss-U.S. privacy Shield policy a company offers shape... Of cures in neurodegenerative disorders, oncology, metabolic and rare genetic diseases a inside. This real connection to the Revance Therapeutics Fourth Quarter and full Year 2022 Results. Meaningful advances in shape therapeutics leadership team for patients, EU-U.S. and Swiss-U.S. privacy Shield policy from shape Therapeutics & # ;... To ensure we meet the needs to solve the underlying cause of many diseases linebut lack the skills or to...
How Did Sheryl Underwood Lose Weight 2021, Why Do Sharks Bleed When Out Of Water, Articles S